Pharmaceutical News

RSS

Technique to reduce the toxicity of vaccines demonstrated

Researchers have demonstrated a technique that has the potential to reduce the toxicity of vaccines and to make smaller doses more effective, according to a study published in PLoS Pathogens.

30 Dec 2005

MIT offer logitics solution to Flu vaccine shortages

Although the flu causes tens of thousands of deaths each year in the United States, vaccine to fight the illness is often in short supply when the flu season is at its peak.

30 Dec 2005

Too high blood-thinner doses harmful to patients

According to a new analysis by cardiologists at the Duke Clinical Research Institute, in the prescribing of common but powerful anti-clotting drugs, 42 percent of patients rushed to emergency rooms with symptoms of a heart attack received doses intended to stop clotting in coronary arteries above the recommended range.

29 Dec 2005

Fake bird flu drugs reach the U.S.

Custom officers in the U.S. have seized 51 shipments of a fake anti-bird flu drug.

19 Dec 2005

Sanofi's human bird flu vaccine tests looking good

French drug company Sanofi Pasteur says early stage trials of an experimental vaccine against H5N1 bird flu have shown it provides a good immune response in humans and is safe.

19 Dec 2005

FDA panel approves vaccine for shingles

According to an FDA advisory panel, studies show that an experimental vaccine to prevent shingles can cut the rate of infection by about half in people 60 and older and help curb related pain.

19 Dec 2005

Canada's first prescription drug atlas maps billions in spending

Researchers at the University of British Columbia Centre for Health Services and Policy Research have developed a comprehensive portrait of pharmaceutical spending in Canada -- more than $20 billion by the end of 2005 -- and assembled the results into a first-of-its-kind atlas.

15 Dec 2005

Companies warned about shonky bird flu remedies

The appearance of so-called bird flu remedies which have hit the market in the U.S. have prompted the Food and Drug Administration (FDA) to issue warnings to nine companies.

14 Dec 2005

More good news - Femara helps prevent the return of breast cancer

In more good news for women suffering from breast cancer a study by the the Swiss drugmaker Novartis has shown that their drug Femara benefits women with hormone-sensitive early breast cancer.

14 Dec 2005

Pfizer to fund independent trial on Celebrex and heart risks

Drug company Pfizer Inc., the maker of Celebrex, will pay for an international study of 20,000 people.

14 Dec 2005

MorphoSys signs agreement with Merck

MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys’s HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.

14 Dec 2005

NHS under pressure to provide new breast cancer drugs

The National Health Service in the UK is being put under considerable pressure by Cancer charities to widen access to a promising new class of breast cancer drug as new evidence suggests the latest treatment is far superior to Tamoxifen, the long established premier drug for women with the early stage of the disease.

12 Dec 2005

Roche chooses partners to help make Tamiflu

The producer of sought after bird flu drug Tamiflu, drug giant Roche, has apparently chosen 12 possible partners to help it churn out enough of the drug.

12 Dec 2005

Botox - other applications

While botulinum toxin A, or BTXA, is widely known for its use in dermatology and aesthetic medicine, a review article in the Journal of Cosmetic Dermatology explores the drug’s other successful applications.

12 Dec 2005

Is the FDA too influenced by big pharma?

The U.S. Food and Drug Administration's (FDA) historically sound reputation could be in jeopardy due to it's possibly too close relationship with the major pharmaceutical companies.

12 Dec 2005

Physicians slow to prescribe newer heart drugs

An analysis of the treatment received by more than 100,000 heart patients has shown that physicians' prescription practices for drugs proven effective for treating heart disease has shown steady improvement over the past three years, cardiologists at the Duke Clinical Research Institute (DCRI) have concluded.

7 Dec 2005

Pharmacists in disagreement over law on morning-after pill

A recent survey of pharmacists in the United States has revealed that as many as 39 percent of respondents are against state laws that would require them to fill prescriptions for emergency contraception known as the morning-after pill.

6 Dec 2005

Mesoblast recruits first patients for pilot clinical trials

Australia's adult stem cell company, Mesoblast Limited, today announced that several patients have now been formally recruited for its Pilot Clinical Trials.

6 Dec 2005

Herceptin - can healthcare afford this expensive drug?

New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.

2 Dec 2005

New anthrax antibody

A new anthrax antibody engineered by scientists at The University of Texas at Austin protects and defends against inhalation anthrax without the use of antibiotics and other more expensive antibodies.

2 Dec 2005